Данилова, Н. В.Шабан, С.2023-11-092023-11-091997Данилова Н. В. Влияние "Вермилата" на клиническое течение сердечной недостаточности у больных ишемической болезнью сердца / Н. В. Данилова, С. Шабан // Проблеми екології та медицини. – 1997. – № 1–2. – С. 80–82.2073-4662 (print)2519-2302 (online)https://repository.pdmu.edu.ua/handle/123456789/22210Administration of the polypeptidal preparation "Vermilat" in a combined treatment of cardial failure, which is caused by ishemic heart disease, has showed a possitive effect on the clinical course of the disease, an increase in the lever of cardiovascular adaptation, and an inhibition of peroxidal oxidation of lipids in patients suffered from this disease.ukсерцева недостатністьішемічна хвороба серцявермілатcardial failureVermilatcoronary heart diseaseArticle616.12-008.46:547.964.4